Manipal Health Enterprises has secured ₹4,167 crore from marquee anchor investors at ₹590 per share before its ₹9,275-crore IPO. The issue, which opens for public subscription on July 29, will use proceeds primarily for debt repayment and strategic acquisitions. Investors should track the company's financial performance, as a significant portion of funds is aimed at reducing subsidiary borrowings.
Manipal Health Enterprises Ltd. has attracted ₹4,167 crore from a group of global and domestic institutional investors through its anchor book allocation. This funding comes just ahead of the company's ₹9,275-crore initial public offering (IPO), which is scheduled to open for public subscription on July 29, 2026, and will remain available until July 31.
Anchor Investor Participation
The anchor portion of the IPO saw significant interest from prominent international and domestic institutions. Global participants included the Abu Dhabi Investment Authority (ADIA), Morgan Stanley Asia, Allianz Global Investors Fund, Natixis International Fund, Societe Generale, and Goldman Sachs Bank Europe. Domestic interest was led by major mutual fund houses, including ICICI Prudential Mutual Fund, Kotak Mutual Fund, Aditya Birla Sun Life Mutual Fund, UTI Mutual Fund, and HSBC Mutual Fund. The company allocated over 7.06 crore shares to these investors at the upper price band of ₹590 per share.
IPO Structure and Valuation
The overall price band for the IPO has been fixed between ₹560 and ₹590 per equity share. At the upper end of this band, the company is valued at more than ₹77,600 crore. The offering consists of a fresh issue of shares worth up to ₹8,000 crore, alongside an offer for sale (OFS) of up to 2.16 crore shares by existing shareholders. Key selling shareholders in the OFS include Imperius Healthcare Investments, Manipal Education and Medical Group India, TPG SG Magazine, and Novo Holdings Invest Asia. The shares are expected to list on the BSE and NSE around August 5.
Financial Context and Use of Funds
For the six months ending September 30, 2025, Manipal Health reported a revenue of ₹4,713 crore and a net profit of ₹571.8 crore. The company intends to direct approximately ₹5,378 crore of the fresh issue proceeds toward the repayment or prepayment of debt held by its subsidiary, Manipal Hospitals Pvt. Ltd. Additionally, ₹574 crore is planned for the acquisition of a minority stake in Sahyadri Hospitals Pvt. Ltd., with the remainder designated for general corporate purposes.
Operational Scale
As of December 31, 2025, the Bengaluru-based healthcare provider maintained an operational network of 49 hospitals spread across 14 states and Union Territories. The facility infrastructure includes a licensed bed capacity of 12,631. The management of the public offer involves several lead managers, including Axis Capital, Kotak Mahindra Capital Company, and Goldman Sachs (India) Securities. As the company moves toward its public listing, investors will likely focus on the effectiveness of the debt reduction strategy and the company's ability to maintain its profit margins while managing its extensive hospital network.